Analysis of the Results of Videotoracoscopic Sympathectomy in the Treatment of Hyperhidrosis in Patients 40 Years or Older

Carregando...
Imagem de Miniatura
Citações na Scopus
5
Tipo de produção
article
Data de publicação
2020
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Autores
FAUSTINO, Carolina B.
KAUFFMAN, Paulo
LEIDERMAN, Dafne Diamante
CUCATO, Gabriel
WOLOSKER, Nelson
Citação
ANNALS OF VASCULAR SURGERY, v.65, p.107-112, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Several factors that could influence the efficacy and satisfaction of patients after bilateral thoracic sympathectomy (video-assisted thoracoscopic sympathectomy [VATS]) in the treatment of hyperhidrosis (HH) have been studied, but no studies in the literature have specifically analyzed the effectiveness of treatment and variations in the quality of life of patients aged 40 years or older compared with those of young adult patients (19-40 years). Methods: We retrospectively analyzed 2,431 HH patients who underwent bilateral VATS and divided the patients into the following groups: a group younger than 40 years old (1,760 patients) and a group 40 years and older (142 patients). Variables included quality of life before surgery, improvement in quality of life after surgery, clinical improvement in sweating, the presence of severe compensatory hyperhidrosis (CH), and general satisfaction at 1 month after surgery. Results: We observed that all surgical patients presented with poor or very poor quality of life before surgery, with similar proportions in both groups. In the postoperative period, we observed improvement in quality of life in more than 90% of the patients, with no significant difference noted between the 2 groups of patients. More than 90% of the patients in this series had great clinical improvement in the main HH site, with no significant difference between the 2 groups. Severe CH occurred in 23.8% of the patients in this series, with no significant difference between the 2 groups. Conclusions: Patients 40 years of age or older benefit just as much as younger patients from VATS performed to treat primary HH, presenting excellent significant surgical results.
Palavras-chave
Referências
  1. Amir M, 2000, ISRAEL J PSYCHIAT, V37, P25
  2. Buraschi J, 2008, ARCH ARGENT PEDIATR, V106, P32
  3. Cameron AEP, 2016, THORAC SURG CLIN, V26, P403, DOI 10.1016/j.thorsurg.2016.06.004
  4. de Campos JRM, 2005, CLIN AUTON RES, V15, P116, DOI 10.1007/s10286-005-0259-6
  5. de Campos JRM, 2003, ANN THORAC SURG, V76, P886
  6. De Campos JRM, 2003, J PNEUMOL, V29, P178
  7. Dharmaraj B, 2016, Clin Ter, V167, P67, DOI 10.7417/CT.2016.1928
  8. DIAS LUCIARA IRENE DE NADAI, 2016, Rev. Col. Bras. Cir., V43, P354, DOI 10.1590/0100-69912016005013
  9. Estevan FA, 2017, AN BRAS DERMATOL, V92, P629, DOI 10.1590/abd1806-4841.20175551
  10. Haider A, 2005, CAN MED ASSOC J, V172, P69, DOI 10.1503/cmaj.1040708
  11. Karimian-Teherani D, 2009, J EUR ACAD DERMATOL, V23, P651, DOI 10.1111/j.1468-3083.2009.03131.x
  12. Lear W, 2007, DERMATOL SURG, V33, pS69, DOI 10.1111/j.1524-4725.2006.32334.x
  13. Lee Seok Soo, 2017, Korean J Thorac Cardiovasc Surg, V50, P197, DOI 10.5090/kjtcs.2017.50.3.197
  14. Lembranca L, 2017, ANN VASC SURG, V43, P283, DOI 10.1016/j.avsg.2017.01.018
  15. Ong W, 2016, SURG ENDOSC, V30, P1219, DOI 10.1007/s00464-015-4335-2
  16. Sammons JE, 2017, J DERMATOL TREAT, V28, P582, DOI 10.1080/09546634.2017.1309347
  17. Strutton DR, 2004, J AM ACAD DERMATOL, V51, P241, DOI 10.1016/j.jaad.2003.12.040
  18. Teivelis MP, 2014, J THORAC CARDIOV SUR, V148, P2443, DOI 10.1016/j.jtcvs.2014.08.025
  19. Wolosker N, 2015, PEDIATR DERMATOL, V32, P663, DOI 10.1111/pde.12385
  20. Wolosker N, 2012, J VASC SURG, V55, P154, DOI 10.1016/j.jvs.2011.07.097